BRD-A68589262-001-04-3 (Substance)

Synonyms:BRD-A68589262-001-04-3
Id:340080732

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-A68589262-001-04-3's neighborhood in the knowledge graph.

Results found

Linked to

 

Label

Description

 

Biosample

A biosample from LINCS produced as part of the L1000 Phase1 project

Biosample

A biosample from LINCS produced as part of the L1000 Phase1 project

Biosample

A biosample from LINCS produced as part of the L1000 Phase1 project

Biosample

A biosample from LINCS produced as part of the LINCS 2021 project

Biosample

A biosample from LINCS produced as part of the LINCS 2021 project

Biosample

A biosample from LINCS produced as part of the LINCS 2021 project

Biosample

A biosample from LINCS produced as part of the LINCS 2021 project

Biosample

A biosample from LINCS produced as part of the L1000 Phase1 project

Biosample

A biosample from LINCS produced as part of the L1000 Phase1 project

Biosample

A biosample from LINCS produced as part of the LINCS 2021 project

  • Biosample

    A biosample from LINCS produced as part of the L1000 Phase1 project


  • Biosample

    A biosample from LINCS produced as part of the L1000 Phase1 project


  • Biosample

    A biosample from LINCS produced as part of the L1000 Phase1 project


  • Biosample

    A biosample from LINCS produced as part of the LINCS 2021 project


  • Biosample

    A biosample from LINCS produced as part of the LINCS 2021 project


  • Biosample

    A biosample from LINCS produced as part of the LINCS 2021 project


  • Biosample

    A biosample from LINCS produced as part of the LINCS 2021 project


  • Biosample

    A biosample from LINCS produced as part of the L1000 Phase1 project


  • Biosample

    A biosample from LINCS produced as part of the L1000 Phase1 project


  • Biosample

    A biosample from LINCS produced as part of the LINCS 2021 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.